BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 16443270)

  • 1. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.
    Chung YI; Tae G; Hong Yuk S
    Biomaterials; 2006 Apr; 27(12):2621-6. PubMed ID: 16360204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles.
    Zweers ML; Engbers GH; Grijpma DW; Feijen J
    J Control Release; 2006 Sep; 114(3):317-24. PubMed ID: 16884807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation.
    Blanco E; Weinberg BD; Stowe NT; Anderson JM; Gao J
    J Biomed Mater Res A; 2006 Jan; 76(1):174-82. PubMed ID: 16265662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
    Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
    Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
    Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
    Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
    Gómez-Gaete C; Tsapis N; Besnard M; Bochot A; Fattal E
    Int J Pharm; 2007 Mar; 331(2):153-9. PubMed ID: 17157461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
    Zolnik BS; Burgess DJ
    J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs.
    Joung YK; Choi JH; Park KM; Park KD
    Biomed Mater; 2007 Dec; 2(4):269-73. PubMed ID: 18458485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.